Clinical Trial Update: DC Vaccine Combined With CIK Cells in Patients With SCLC [Phase 1, Phase 2]

View source ↗

Summary

The document describes an early-phase clinical trial testing a dendritic cell vaccine combined with cytokine-induced killer cells in patients with small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CIK Cells
• DC Vaccine

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Small- Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN